GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Healthcare Services Acquisition Corp (NAS:HCAR) » Definitions » ROE %

Healthcare Services Acquisition (Healthcare Services Acquisition) ROE % : 3.22% (As of Sep. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Healthcare Services Acquisition ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Healthcare Services Acquisition's annualized net income for the quarter that ended in Sep. 2022 was $10.11 Mil. Healthcare Services Acquisition's average Total Stockholders Equity over the quarter that ended in Sep. 2022 was $314.14 Mil. Therefore, Healthcare Services Acquisition's annualized ROE % for the quarter that ended in Sep. 2022 was 3.22%.

The historical rank and industry rank for Healthcare Services Acquisition's ROE % or its related term are showing as below:

HCAR's ROE % is not ranked *
in the Diversified Financial Services industry.
Industry Median: 0.745
* Ranked among companies with meaningful ROE % only.

Healthcare Services Acquisition ROE % Historical Data

The historical data trend for Healthcare Services Acquisition's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Healthcare Services Acquisition ROE % Chart

Healthcare Services Acquisition Annual Data
Trend Dec20 Dec21
ROE %
- 3.56

Healthcare Services Acquisition Quarterly Data
Aug20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
ROE % Get a 7-Day Free Trial 6.34 4.49 4.81 6.95 3.22

Competitive Comparison of Healthcare Services Acquisition's ROE %

For the Shell Companies subindustry, Healthcare Services Acquisition's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Healthcare Services Acquisition's ROE % Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Healthcare Services Acquisition's ROE % distribution charts can be found below:

* The bar in red indicates where Healthcare Services Acquisition's ROE % falls into.



Healthcare Services Acquisition ROE % Calculation

Healthcare Services Acquisition's annualized ROE % for the fiscal year that ended in Dec. 2021 is calculated as

ROE %=Net Income (A: Dec. 2021 )/( (Total Stockholders Equity (A: Dec. 2020 )+Total Stockholders Equity (A: Dec. 2021 ))/ count )
=10.617/( (293.2+303.817)/ 2 )
=10.617/298.5085
=3.56 %

Healthcare Services Acquisition's annualized ROE % for the quarter that ended in Sep. 2022 is calculated as

ROE %=Net Income (Q: Sep. 2022 )/( (Total Stockholders Equity (Q: Jun. 2022 )+Total Stockholders Equity (Q: Sep. 2022 ))/ count )
=10.108/( (312.878+315.405)/ 2 )
=10.108/314.1415
=3.22 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Sep. 2022) net income data. ROE % is displayed in the 30-year financial page.


Healthcare Services Acquisition  (NAS:HCAR) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Sep. 2022 )
=Net Income/Total Stockholders Equity
=10.108/314.1415
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(10.108 / 0)*(0 / 332.5895)*(332.5895 / 314.1415)
=Net Margin %*Asset Turnover*Equity Multiplier
=N/A %*0*1.0587
=ROA %*Equity Multiplier
=N/A %*1.0587
=3.22 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Sep. 2022 )
=Net Income/Total Stockholders Equity
=10.108/314.1415
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (10.108 / 11.588) * (11.588 / -1.044) * (-1.044 / 0) * (0 / 332.5895) * (332.5895 / 314.1415)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.8723 * -11.0996 * N/A % * 0 * 1.0587
=3.22 %

Note: The net income data used here is four times the quarterly (Sep. 2022) net income data. The Revenue data used here is four times the quarterly (Sep. 2022) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Healthcare Services Acquisition ROE % Related Terms

Thank you for viewing the detailed overview of Healthcare Services Acquisition's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Healthcare Services Acquisition (Healthcare Services Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
7809 Woodmont Avenue, Suite 200, Bethesda, MD, USA, 20814
Healthcare Services Acquisition Corp is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
Executives
Brian T Griffin director
David T Blair director, officer: CEO and Chairman of the Board HEALTHEXTRAS, INC, 800 KING FARM BLVD, 4TH FL, ROCKVILLE MD 20850
Michael P Donovan director HEALTHEXTRAS, INC, 800 KING FARM BLVD, 4TH FL, ROCKVILLE MD 20850
Jeanne L. Manischewitz director 7809 WOODMONT AVENUE, SUITE 200, BETHESDA MD 20814
Martin J. Payne director, officer: President and Director 7809 WOODMONT AVENUE, SUITE 200, BETHESDA MD 20814
Joshua B. Lynn officer: Chief Financial Officer 7809 WOODMONT AVENUE, SUITE 200, BETHESDA MD 20814
Tao Tan officer: Chief Operating Officer 7809 WOODMONT AVENUE, SUITE 200, BETHESDA MD 20814